İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2016

Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey

YÖKSİS OpenAlex Açık erişim · gold SJR Q1 JCR Q2 Atıf 35 Yüzdelik 79.7% FWCI 1.14
Yıl
2016
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Health and Quality of Life Outcomes
  • Katalog eşleşmesi (ISSN) Health and Quality of Life Outcomes
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

BACKGROUND: The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. METHODS: This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. RESULTS: Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. CONCLUSIONS: The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

35 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yazarlar

  1. ZEHRA KARACAER
  2. BANU ÇAKIR
  3. HAKAN ERDEM
  4. KENAN UĞURLU
  5. GÜL DURMUŞ
  6. NEVİN KOÇ İNCE
  7. ÇINAR ÖZTÜRK
  8. RODRİGO HASBUN
  9. AYŞE BATIREL
  10. ESMERAY MUTLU YILMAZ
  11. İLKAY BOZKURT
  12. MUSTAFA SÜNBÜL
  13. AYNUR AYNİOĞLU
  14. AYNUR ATİLLA
  15. AYŞE ERBAY
  16. AYŞE İNCİ
  17. ÇİĞDEM KADER
  18. ELİF TÜKENMEZ TİGEN
  19. GÖKHAN KARAAHMETOĞLU
  20. SEHER AYTEN COŞKUNER
  21. EBRU DİK
  22. HÜSEYİN TARAKÇI
  23. SELMA TOSUN
  24. FATİMA KORKMAZ
  25. CEYDA KOCAOĞLU
  26. AHMET MELİH ŞAHİN
  27. PINAR ERGEN
  28. GÜLŞEN İSKENDER
  29. PINAR KORKMAZ
  30. ESMA GÜLESEN EROĞLU
  31. YASEMİN DURDU
  32. MEHMET ULUĞ
  33. SUNA SEÇİL DENİZ
  34. FİLİZ KOÇ
  35. SAYGIN NAYMAN
  36. NEFİSE ÖZTOPRAK
  37. ÖMER EVİRGEN
  38. HAMDİ SÖZEN
  39. MUSTAFA DOĞAN
  40. SELÇUK KAYA ÇANAKKALE ONSEKİZ MART ÜNİVERSİTESİ
  41. ŞAFAK KAYA
  42. MUSTAFA ALTINDİŞ SAKARYA ÜNİVERSİTESİ
  43. EMEL ASLAN
  44. RECEP TEKİN
  45. BÜŞRA ERGUT SEZER
  46. GÜLDEN ERSÖZ
  47. AHMET ŞAHİN GAZİANTEP İSLAM BİLİM VE TEKNOLOJİ ÜNİVERSİTESİ
  48. EMSAL AYDIN GİRESUN ÜNİVERSİTESİ
  49. ALİYE BAŞTUĞ
  50. REZAN HARMAN
  51. HACER DENİZ ÖZKAYA
  52. EMİNE PARLAK
  53. İLKNUR ŞENEL
  54. SUZAN SAÇAR
  55. ŞENOL ÇOMOĞLU
  56. ERCAN YENİLMEZ
  57. FATMA SIRMATEL
  58. İLKER İNANÇ BALKAN
  59. YEŞİM ÇAĞLAR BALIKESİR ÜNİVERSİTESİ
  60. MUSTAFA HATİBOĞLU
  61. AFFAN DENK
  62. GÜNEŞ ŞENOL
  63. MEHMET BİTİRGEN
  64. MEHMET FARUK GEYİK
  65. HATİCE RAHMET GÜNER
  66. AYTEN KADANALI
  67. MUSTAFA NAMIDURU
  68. HATİCE UDURGUCU
  69. RUKİYE PINAR BÖLÜKTAŞ
  70. ERGENEKON AND KARAGÖZ